Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Lancet. Diabetes & Endocrinology|March 13, 2016
Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitusChristian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad
Expert Review of Clinical Pharmacology|March 29, 2017
Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetesLauge Østergaard, Christian Seerup Frandsen, Thomas Fremming Dejgaard, et al.
Expert Opinion on Pharmacotherapy|July 12, 2018
Non-insulin pharmacological therapies for treating type 1 diabetesChristian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad, et al.
Expert Opinion on Biological Therapy|March 2, 2016
Liraglutide for treating type 1 diabetesThomas Fremming Dejgaard, Christian Seerup Frandsen, Jens Juul Holst, et al.
Expert Opinion on Emerging Drugs|December 9, 2016
Emerging drugs for the treatment of obesityChristoffer Martinussen, Kirstine Nyvold Bojsen-Moller, Maria Saur Svane, et al.
BMJ Open|June 29, 2018
Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trialNicklas Järvelä Johansen, Thomas Fremming Dejgaard, Asger Lund, et al.
Journal of Diabetes and Its Complications|July 22, 2017
Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathyJesper Fleischer, Esben Laugesen, Simon Lebech Cichosz, et al.
BMJ Open|April 4, 2015
Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 studyThomas Fremming Dejgaard, Filip Krag Knop, Lise Tarnow, et al.
Frontiers in Endocrinology|April 30, 2019
Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 DiabetesChristian Stevns Hansen, Christian Seerup Frandsen, Jesper Fleischer, et al.
The Lancet Regional Health. Europe|May 28, 2026
Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018-2024)Puriya Daniel Würtz Yazdanfard, Vanja Kosjerina, Hannah Karin Wood-Kurland, et al.
Pageof 2